Study design, ethical approval, and registration
The pilot study employed a randomized, double-blind placebo-controlled design with two parallel arms. The project was approved by the Swedish ethical review authority, Sweden (Dnr 2020-05221) and registered in Clinical Trials.gov Identifier (NCT05033015).